← Return to Boosters reduce vulnerability to COVID-19 variants
Newsfeed PostNewsfeed Post in blog Podcasts
Boosters reduce vulnerability to COVID-19 variants Dec 9, 2021 | By Jennifer O'Hara (@jenohara)Comment receiving replies
Replies to "I was a participant in the 3rd stage clinical trial for the Novavax vaccine. I speak..."
@joedlh I can certainly understand your concerns and desire for the booster at the same time. What is the commitment and direction you've received from the trial with regard to this given your concern for your personal health and well-being?